Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.

Huber MB, Wacker ME, Vogelmeier CF, Leidl R.

PLoS One. 2015 Apr 13;10(4):e0123292. doi: 10.1371/journal.pone.0123292. eCollection 2015.

2.

Assessing the drug release from nanoparticles: Overcoming the shortcomings of dialysis by using novel optical techniques and a mathematical model.

Xie L, Beyer S, Vogel V, Wacker MG, Mäntele W.

Int J Pharm. 2015 Jul 5;488(1-2):108-19. doi: 10.1016/j.ijpharm.2015.03.080. Epub 2015 Apr 4.

PMID:
25847513
3.

Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.

Ihssen J, Haas J, Kowarik M, Wiesli L, Wacker M, Schwede T, Thöny-Meyer L.

Open Biol. 2015 Apr;5(4):140227. doi: 10.1098/rsob.140227.

4.

Matching Pursuit Based Time-Variant Bispectral Analysis and its Application to Biomedical Signals.

Schiecke K, Wacker M, Benninger F, Feucht M, Leistritz L, Witte H.

IEEE Trans Biomed Eng. 2015 Feb 26. [Epub ahead of print]

PMID:
25730821
5.

Advantages of signal-adaptive approaches for the nonlinear, time-variant analysis of heart rate variability of children with temporal lobe epilepsy.

Schiecke K, Wacker M, Benninger F, Feucht M, Leistritz L, Witte H.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:6377-80. doi: 10.1109/EMBC.2014.6945087.

PMID:
25571455
6.

Nanoencapsulation of ultra-small superparamagnetic particles of iron oxide into human serum albumin nanoparticles.

Wacker MG, Altinok M, Urfels S, Bauer J.

Beilstein J Nanotechnol. 2014 Nov 27;5:2259-66. doi: 10.3762/bjnano.5.235. eCollection 2014.

7.

Cardiac thromboxane A2 receptor activation does not directly induce cardiomyocyte hypertrophy but does cause cell death that is prevented with gentamicin and 2-APB.

Touchberry CD, Silswal N, Tchikrizov V, Elmore CJ, Srinivas S, Akthar AS, Swan HK, Wetmore LA, Wacker MJ.

BMC Pharmacol Toxicol. 2014 Dec 17;15:73. doi: 10.1186/2050-6511-15-73.

8.

Bridging laboratory and large scale production: preparation and in vitro-evaluation of photosensitizer-loaded nanocarrier devices for targeted drug delivery.

Beyer S, Xie L, Gräfe S, Vogel V, Dietrich K, Wiehe A, Albrecht V, Mäntele W, Wacker MG.

Pharm Res. 2015 May;32(5):1714-26. doi: 10.1007/s11095-014-1569-y. Epub 2014 Nov 19.

PMID:
25407544
9.

Distal radius: anatomical morphometric gender characteristics. Do anatomical pre-shaped plates pay attention on it?

Oppermann J, Bredow J, Beyer F, Neiss WF, Spies CK, Eysel P, Dargel J, Wacker M.

Arch Orthop Trauma Surg. 2015 Jan;135(1):133-9. doi: 10.1007/s00402-014-2112-7. Epub 2014 Nov 12.

PMID:
25388864
10.

Occlusive gloves and skin conditions: is there a problem? Results of a cross-sectional study in a semiconductor company.

Weistenhöfer W, Wacker M, Bernet F, Uter W, Drexler H.

Br J Dermatol. 2015 Apr;172(4):1058-65. doi: 10.1111/bjd.13481. Epub 2015 Feb 27.

PMID:
25319754
11.

Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.

Hoogendoorn M, Feenstra TL, Asukai Y, Borg S, Hansen RN, Jansson SA, Samyshkin Y, Wacker M, Briggs AH, Lloyd A, Sullivan SD, Rutten-van Mölken MP.

Value Health. 2014 Jul;17(5):525-36. doi: 10.1016/j.jval.2014.03.1721. Epub 2014 May 14.

PMID:
25128045
12.

Anatomical fit of seven different palmar distal radius plates.

Oppermann J, Wacker M, Stein G, Springorum HP, Neiss WF, Burkhart KJ, Eysel P, Dargel J.

Arch Orthop Trauma Surg. 2014 Oct;134(10):1483-9. doi: 10.1007/s00402-014-2072-y. Epub 2014 Aug 10.

PMID:
25108754
13.

Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population.

Wacker ME, Hunger M, Karrasch S, Heinrich J, Peters A, Schulz H, Holle R.

BMC Pulm Med. 2014 Aug 9;14:134. doi: 10.1186/1471-2466-14-134.

14.

FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.

Silswal N, Touchberry CD, Daniel DR, McCarthy DL, Zhang S, Andresen J, Stubbs JR, Wacker MJ.

Am J Physiol Endocrinol Metab. 2014 Sep 1;307(5):E426-36. doi: 10.1152/ajpendo.00264.2014. Epub 2014 Jul 22.

PMID:
25053401
15.

Time-variant, frequency-selective, linear and nonlinear analysis of heart rate variability in children with temporal lobe epilepsy.

Schiecke K, Wacker M, Piper D, Benninger F, Feucht M, Witte H.

IEEE Trans Biomed Eng. 2014 Jun;61(6):1798-808. doi: 10.1109/TBME.2014.2307481.

PMID:
24845290
16.

Sunlight and Vitamin D: A global perspective for health.

Wacker M, Holick MF.

Dermatoendocrinol. 2013 Jan 1;5(1):51-108. doi: 10.4161/derm.24494. Review.

17.

Nanotherapeutics--product development along the "nanomaterial" discussion.

Wacker MG.

J Pharm Sci. 2014 Mar;103(3):777-84. doi: 10.1002/jps.23879. Epub 2014 Jan 30. Review.

PMID:
24481705
18.

Metabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolism.

Lewis IA, Wacker M, Olszewski KL, Cobbold SA, Baska KS, Tan A, Ferdig MT, Llinás M.

PLoS Genet. 2014 Jan;10(1):e1004085. doi: 10.1371/journal.pgen.1004085. Epub 2014 Jan 2.

19.

Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.

Wacker M, Wang L, Kowarik M, Dowd M, Lipowsky G, Faridmoayer A, Shields K, Park S, Alaimo C, Kelley KA, Braun M, Quebatte J, Gambillara V, Carranza P, Steffen M, Lee JC.

J Infect Dis. 2014 May 15;209(10):1551-61. doi: 10.1093/infdis/jit800. Epub 2013 Dec 5.

20.

Nanocarriers for intravenous injection--the long hard road to the market.

Wacker M.

Int J Pharm. 2013 Nov 30;457(1):50-62. doi: 10.1016/j.ijpharm.2013.08.079. Epub 2013 Sep 12. Review.

PMID:
24036012
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk